Presentation Information
[27-13-am03S]Development of a new molecular targeted cancer therapeutics via activation of the tumor suppressor p53 pathway
○Yukichika Yasuki1,2, Kazunari Arima2, Keita Yamashita1,2, Michiko Shimokawa 1, Takuto Kawahata1, Kazumasa Sekihara1, Tatsuhiko Furukawa1, Kohichi Kawahara1 (1. Grad. Sch. Med. Dent. Sci., Kagoshima Univ., 2. Grad. Sch. Sci. Eng., Kagoshima Univ.)